β-Carboline
| Names | |
|---|---|
| Preferred IUPAC name
9H-Pyrido[3,4-b]indole | |
Other names
| |
| Identifiers | |
3D model (JSmol) |
|
| 128414 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.005.418 |
| EC Number |
|
| KEGG | |
| MeSH | norharman |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C11H8N2 | |
| Molar mass | 168.20 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
β-Carboline, also known as norharman, norharmane, or 9H-pyrido[3,4-b]indole, is a tricyclic chemical compound and alkaloid. It is the parent structure of the substituted β-carbolines, a large group of alkaloids and synthetic compounds. β-Carboline may be thought of as a cyclized tryptamine. The compound has been found to possess a variety of pharmacological activities, including DNA mutagenic effects, imidazoline receptor interactions, serotonin reuptake inhibition, monoamine oxidase inhibition, cytochrome P450 enzyme inhibition, and inhibition of other enzymes, among others.
β-Carboline is a weak reversible inhibitor of monoamine oxidase A (RIMA), with an IC50 of 1,700 nM. It is also a weak dopamine reuptake inhibitor (DRI), with an IC50 of 3,040 nM at the dopamine transporter (DAT). The drug shows weak affinity for the serotonin 5-HT2B and 5-HT2C receptors (Ki = 738 nM and 2,522 nM, respectively), but not for the serotonin 5-HT2A receptor (Ki = >10,000 nM).